Related references
Note: Only part of the references are listed.Dynamic patterns of microRNA expression during acute myeloid leukemia state-transition
David E. Frankhouser et al.
SCIENCE ADVANCES (2022)
Treatment of blast phase chronic myeloid leukaemia: A rare and challenging entity
Mhairi Copland
BRITISH JOURNAL OF HAEMATOLOGY (2022)
Mutations in the miR-142 gene are not common in myeloproliferative neoplasms
Paulina Galka-Marciniak et al.
SCIENTIFIC REPORTS (2022)
RNA therapy: rich history, various applications and unlimited future prospects
Young-Kook Kim
EXPERIMENTAL AND MOLECULAR MEDICINE (2022)
Targeting Energy Metabolism in Cancer Stem Cells: Progress and Challenges in Leukemia and Solid Tumors
Courtney L. Jones et al.
CELL STEM CELL (2021)
Chronic myeloid leukemia stem cells: targeting therapeutic implications
Hanieh Mojtahedi et al.
STEM CELL RESEARCH & THERAPY (2021)
The Limitless Future of RNA Therapeutics
Tulsi Ram Damase et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2021)
Treatment-induced arteriolar revascularization and miR-126 enhancement in bone marrow niche protect leukemic stem cells in AML
Bin Zhang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
Chronic myeloid leukaemia
Jorge Cortes et al.
LANCET (2021)
Downregulation of miR-142a Contributes to the Enhanced Anti-Apoptotic Ability of Murine Chronic Myelogenous Leukemia Cells
Zhiwei Chen et al.
FRONTIERS IN ONCOLOGY (2021)
Myeloid cell-targeted miR-146a mimic inhibits NF-κB-driven inflammation and leukemia progression in vivo
Yu-Lin Su et al.
BLOOD (2020)
CPT1A-mediated Fat Oxidation, Mechanisms, and Therapeutic Potential
Isabel R. Schlaepfer et al.
ENDOCRINOLOGY (2020)
State-Transition Analysis of Time-Sequential Gene Expression Identifies Critical Points That Predict Development of Acute Myeloid Leukemia
Russell C. Rockne et al.
CANCER RESEARCH (2020)
Oxidative Metabolism Drives Immortalization of Neural Stem Cells during Tumorigenesis
Francois Bonnay et al.
CELL (2020)
Expression differences of miR-142-5p between treatment-naive chronic myeloid leukemia patients responding and non-responding to imatinib therapy suggest a link to oncogenic ABL2, SRI, cKIT and MCL1 signaling pathways critical for development of therapy resistance
Theresa Kluemper et al.
EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2020)
Mir142 loss unlocks IDH2R140-dependent leukemogenesis through antagonistic regulation of HOX genes
A. Marshall et al.
SCIENTIFIC REPORTS (2020)
The leukaemia stem cell: similarities, differences and clinical prospects in CML and AML
David Vetrie et al.
NATURE REVIEWS CANCER (2020)
Denervation drives skeletal muscle atrophy and induces mitochondrial dysfunction, mitophagy and apoptosis via miR-142a-5p/MFN1 axis
Xiaofan Yang et al.
THERANOSTICS (2020)
miR-142 controls metabolic reprogramming that regulates dendritic cell activation
Yaping Sun et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Rationale for Targeting Deregulated Metabolic Pathways as a Therapeutic Strategy in Acute Myeloid Leukemia
Nicolas Chapuis et al.
FRONTIERS IN ONCOLOGY (2019)
MicroRNA-142 Is Critical for the Homeostasis and Function of Type 1 Innate Lymphoid Cells
Melissa M. Berrien-Elliott et al.
IMMUNITY (2019)
The Bcl-2 inhibitor venetoclax inhibits Nrf2 antioxidant pathway activation induced by hypomethylating agents in AML
Le Xuan Truong Nguyen et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Mitochondrial fusion supports increased oxidative phosphorylation during cell proliferation
Cong-Hui Yao et al.
ELIFE (2019)
MIR142 Loss-of-Function Mutations Derepress ASH1L to Increase HOXA Gene Expression and Promote Leukemogenesis
Maria C. Trissal et al.
CANCER RESEARCH (2018)
Guidelines and considerations for the use of system suitability and quality control samples in mass spectrometry assays applied in untargeted clinical metabolomic studies
David Broadhurst et al.
METABOLOMICS (2018)
Bone marrow niche trafficking of miR-126 controls the self-renewal of leukemia stem cells in chronic myelogenous leukemia
Bin Zhang et al.
NATURE MEDICINE (2018)
The CPT1a inhibitor, etomoxir induces severe oxidative stress at commonly used concentrations
Roddy S. O'Connor et al.
SCIENTIFIC REPORTS (2018)
Direct role of FLT3 in regulation of early lymphoid progenitors
Alya Zriwil et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
Transcriptome-wide analysis uncovers the targets of the RNA-binding protein MSI2 and effects of MSI2's RNA-binding activity on IL-6 signaling
Sujitha Duggimpudi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
A relative quantitative positive/negative ion switching method for untargeted lipidomics via high resolution LC-MS/MS from any biological source
Susanne B. Breitkopf et al.
METABOLOMICS (2017)
Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells
Elodie M. Kuntz et al.
NATURE MEDICINE (2017)
Single-cell transcriptomics uncovers distinct molecular signatures of stem cells in chronic myeloid leukemia
Alice Giustacchini et al.
NATURE MEDICINE (2017)
Immunomodulation: A definitive role of microRNA-142
Salil Sharma
DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY (2017)
MicroRNA-142 is a multifaceted regulator in organogenesis, homeostasis, and disease
Amit Shrestha et al.
DEVELOPMENTAL DYNAMICS (2017)
Metabolomics Workbench: An international repository for metabolomics data and metadata, metabolite standards, protocols, tutorials and training, and analysis tools
Manish Sud et al.
NUCLEIC ACIDS RESEARCH (2016)
A single-cell resolution map of mouse hematopoietic stem and progenitor cell differentiation
Sonia Nestorowa et al.
BLOOD (2016)
Genome-wide analysis of Musashi-2 targets reveals novel functions in governing epithelial cell migration
Christopher G. Bennett et al.
NUCLEIC ACIDS RESEARCH (2016)
Probing metabolic states of differentiating stem cells using two-photon FLIM
Aleksandra V. Meleshina et al.
SCIENTIFIC REPORTS (2016)
Carnitine transporter CT2 (SLC22A16) is over-expressed in acute myeloid leukemia (AML) and target knockdown reduces growth and viability of AML cells
Yan Wu et al.
APOPTOSIS (2015)
Altered lymphopoiesis and immunodeficiency in miR-142 null mice
Nicholas J. Kramer et al.
BLOOD (2015)
Targeting the leukemia cell metabolism by the CPT1a inhibition: functional preclinical effects in leukemias
Maria Rosaria Ricciardi et al.
BLOOD (2015)
The emerging role of Nrf2 in mitochondrial function
Albena T. Dinkova-Kostova et al.
FREE RADICAL BIOLOGY AND MEDICINE (2015)
Mature T cell responses are controlled by microRNA-142
Yaping Sun et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
miR-24, miR-30b, and miR-142-3p Regulate Phagocytosis in Myeloid Inflammatory Cells
Afsar Raza Naqvi et al.
JOURNAL OF IMMUNOLOGY (2015)
Up-regulated MSI2 is associated with more aggressive chronic myeloid leukemia
Jaspal Kaeda et al.
LEUKEMIA & LYMPHOMA (2015)
Transformation of the intestinal epithelium by the MSI2 RNA-binding protein
Shan Wang et al.
NATURE COMMUNICATIONS (2015)
Clinical and functional implications of microRNA mutations in a cohort of 935 patients with myelodysplastic syndromes and acute myeloid leukemia
Felicitas Thol et al.
HAEMATOLOGICA (2015)
miR-142-3p regulates the formation and differentiation of hematopoietic stem cells in vertebrates
Xinyan Lu et al.
CELL RESEARCH (2013)
BCL-2 Inhibition Targets Oxidative Phosphorylation and Selectively Eradicates Quiescent Human Leukemia Stem Cells
Eleni D. Lagadinou et al.
CELL STEM CELL (2013)
miR-142-3p Controls the Specification of Definitive Hemangioblasts during Ontogeny
Rachael Nimmo et al.
DEVELOPMENTAL CELL (2013)
Altered Microenvironmental Regulation of Leukemic and Normal Stem Cells in Chronic Myelogenous Leukemia
Bin Zhang et al.
CANCER CELL (2012)
miR-29a and miR-142-3p downregulation and diagnostic implication in human acute myeloid leukemia
Fang Wang et al.
MOLECULAR BIOLOGY REPORTS (2012)
Musashi2 Is Required for the Self-Renewal and Pluripotency of Embryonic Stem Cells
Erin L. Wuebben et al.
PLOS ONE (2012)
Mitochondrial Fission, Fusion, and Stress
Richard J. Youle et al.
SCIENCE (2012)
MicroRNA-142 is mutated in about 20% of diffuse large B-cell lymphoma
Wiyada Kwanhian et al.
CANCER MEDICINE (2012)
Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution
Keiko Taguchi et al.
GENES TO CELLS (2011)
Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry
Warwick B. Dunn et al.
NATURE PROTOCOLS (2011)
New insight into cancer therapeutics: Induction of differentiation by regulating the Musashi/Numb/Notch pathway
Yoshinori Nishimoto et al.
CELL RESEARCH (2010)
Proteomic analysis of Nrf2 deficient transgenic mice reveals cellular defence and lipid metabolism as primary Nrf2-dependent pathways in the liver
Neil R. Kitteringham et al.
JOURNAL OF PROTEOMICS (2010)
Regulation of myeloid leukaemia by the cell-fate determinant Musashi
Takahiro Ito et al.
NATURE (2010)
Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemia
Michael G. Kharas et al.
NATURE MEDICINE (2010)
In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responses
Marcin Kortylewski et al.
NATURE BIOTECHNOLOGY (2009)
SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells
MJ Kiel et al.
CELL (2005)
Inducible chronic phase of myeloid leukemia with expansion of hematopoietic stem cells in a transgenic model of BCR-ABL leukemogenesis
S Koschmieder et al.
BLOOD (2005)
Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML
CHM Jamieson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Real-time quantitative PCR analysis can be used as a primary screen to identify patients with CML treated with imatinib who have BCR-ABL kinase domain mutations
S Branford et al.
BLOOD (2004)
Estimating mutual information -: art. no. 066138
A Kraskov et al.
PHYSICAL REVIEW E (2004)
Phosphorylation of Nrf2 at Ser40 by protein kinase C in response to antioxidants leads to the release of Nrf2 from INrf2, but is not required for Nrf2 stabilization/accumulation in the nucleus and transcriptional activation of antioxidant response element-mediated NAD(P)H:quinone oxidoreductase-1 gene expression
DA Bloom et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
A clonogenic common myeloid progenitor that gives rise to all myeloid lineages
K Akashi et al.
NATURE (2000)